HOUSTON, April 14, 2016 -- PennTex Midstream Partners, LP (NASDAQ:PTXP) (the “Partnership”) will report first quarter 2016 financial and operating results before the market opens for trading on May 6, 2016. Following the announcement, the Partnership’s management will host a first quarter 2016 earnings conference call at 9:00 a.m. Eastern time (8:00 a.m. Central time).
Interested parties are invited to participate on the call by dialing (877) 710-5977, or (720) 634-9959 for international calls, (Conference ID: 74515258) or via the Partnership’s website at www.penntex.com. A replay of the conference call will be available following the call and can be accessed from www.penntex.com.
About PennTex Midstream Partners, LP
PennTex Midstream Partners, LP is a growth-oriented master limited partnership focused on owning, operating, acquiring and developing midstream energy infrastructure assets in North America. PTXP provides natural gas gathering and processing and residue gas and natural gas liquids transportation services to producers in the Terryville Complex in northern Louisiana. For more information, visit www.penntex.com.
For further information, please direct all inquiries to:
Investor Relations: Andrejka Bernatova
Vice President, Finance and Investor Relations
Email: [email protected]
Telephone: (832) 456-4025
Media: Chris Staffel
Vice President, Administration
Email: [email protected]
Telephone: (832) 456-4005


Niigata Set to Approve Restart of Japan’s Largest Nuclear Power Plant in Major Energy Shift
South Korean Court Clears Korea Zinc’s $7.4 Billion U.S. Smelter Project, Shares Surge
Moore Threads Unveils New GPUs, Fuels Optimism Around China’s AI Chip Ambitions
Mexico Antitrust Review of Viva Aerobus–Volaris Deal Signals Growth for Airline Sector
Boeing Wins $2.04B U.S. Air Force Contract for B-52 Engine Replacement Program
Texas App Store Age Verification Law Blocked by Federal Judge in First Amendment Ruling
FDA Approves Mitapivat for Anemia in Thalassemia Patients
ByteDance Plans Massive AI Investment in 2026 to Close Gap With U.S. Tech Giants
AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study
Seatrium Reaches $475 Million Settlement With Maersk Over Offshore Wind Vessel Project
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccines Portfolio
Warner Bros Discovery Weighs Amended Paramount Skydance Bid as Netflix Takeover Battle Intensifies
JPMorgan’s Top Large-Cap Pharma Stocks to Watch in 2026
California Regulator Probes Waymo Robotaxi Stalls During San Francisco Power Outage
FTC Praises Instacart for Ending AI Pricing Tests After $60M Settlement
Roche CEO Warns US Drug Price Deals Could Raise Costs of New Medicines in Switzerland
John Carreyrou Sues Major AI Firms Over Alleged Copyrighted Book Use in AI Training 



